Intraoperative neurophysiological monitoring

,

A basic principle of modern neurosurgery is the monitoring of brain functions during a surgical procedure: Intraoperative neuromonitoring (also known as intraoperative neurophysiology, intraoperative neurophysiological monitoring, IOMN or IOM) uses neurophysiological techniques to monitor and protect the functions of the nervous system. The goal is to avoid neurological damage during surgery, especially when performing procedures near delicate neurological structures, and thus maximize patient safety.

Intraoperative neurophysiological monitoring (IONM) is a specialty of our clinic. We are one of the leading international clinics in this field, especially in terms of technological equipment, intraoperative methods, experience, number of patients and number of scientific publications. Our clinic has been and continues to be significantly involved in the development of new techniques to avoid neurological deficits worldwide.

3
completely new techniques developed
45
international publications
> 6400
surgeries with neuromonitoring

Why intraoperative neurophysiological monitoring?

There are two concepts during each operation:

  1. Achievement of the surgical objective, e.g. radical removal of the tumor
  2. Avoiding neurological deficits through surgery that reduce the patient's quality of life *, *.

Therefore, every operation must be function-guided*, *, *, *, *, *. The focus is on the following points:

Prevention of nerve damage

IONM can be used to detect changes in nerve function that could indicate impending damage at an early stage.

Support for surgical decision-making

IONM provides real-time information during the procedure to help surgeons access, navigate and perform the operation.

Increased patient safety

The risk of postoperative neurological deficits can be significantly reduced by IONM techniques, as the surgeon can react immediately to potential damage.

What IONM procedures are there?

Monitoring

The methods of intraoperative neuromonitoring include, on the one hand, methods that constantly stimulate a known functional site of the brain and nerve tissue during the operation and thus monitor it. 

Monitoring

Mapping

On the other hand, there are methods that use a kind of "search radar" to detect still unknown functional tissue in the vicinity of the surgical field and provide a timely warning of its location, a process called mapping.

Mapping

Awake brain surgery

Awake brain surgery is also part of the IONM because it makes it possible to monitor the function of critical brain areas in real time by keeping the patient awake and responsive during surgery. This helps to preserve important functions such as speech and movement by directly mapping the corresponding brain regions and avoiding damage.

Awake brain surgery

In which operations is intraoperative neuromonitoring used?

Brain tumors

A complete or almost complete resection (gross total resection or GTR) remains the gold standard for most intracranial tumor surgeries. Evidence for this exists for glioblastomas as well as for astrocytomas, oligodendrogliomas and other gliomas  *, *, *, *, *, *, *.

Whether a brain tumor can be operated on at all depends primarily on its location and proximity to critical brain functions. Based on MRI images, 10–20% of all brain tumors are incorrectly assessed as "eloquent" and inoperable  *, *, *. Only intraoperative mapping and monitoring can show in reality whether a tumor previously assessed as inoperable is really inoperable  *. In the majority of cases, such a tumor can still be safely operated on using special mapping methods.

Brain tumors

Brain aneurysms

When clipping aneurysms, it is important that the large artery remains open while the aneurysm sac is completely clipped – that is, closed. It is known from many studies that this is not perfectly achieved in about 10% of all operations. In these cases, intraoperative neuromonitoring helps to immediately detect critical circulatory disorders. We use monitoring of motor function and sensory perception in almost all aneurysm operations. Both are performed under anesthesia.

Aneurysm of a cerebral artery

Spinal cord tumors

In this type of surgery, the motor pathways are particularly at risk. In most cases, the tumor is located in the immediate vicinity of one or both pathways, and their injury can result in paraplegia. Spinal cord surgery must always be performed with extensive monitoring of motor evoked potentials (MEP), sensory evoked potentials (SEP), D-wave and, if necessary, with mapping of the posterior columns and the pyramidal tract.

Spinal cord tumors

Vestibular schwannomas

In vestibular schwannomas, hearing and facial nerve function are of particular importance. The facial nerve is often fused with the tumor capsule. During surgery, 7 different monitoring techniques are used simultaneously.

Vestibular schwannoma

Brainstem tumors

The nuclei of the cranial nerves and all the pathways that run between the brain and spinal cord are located in the brainstem. Along with the spinal cord, it is the area with the highest concentration of important functions. Surgery in this area requires extensive intraoperative neuromonitoring with up to eight different techniques at the same time.

Operations on the brainstem or skull base

References

  1. Chang EF, Clark A, Smith JS, et al. Functional mapping-guided resection of low-grade gliomas in eloquent areas of the brain: improvement of long-term survival. Clinical article. Journal of neurosurgery 2011;114(3):566-73.

  2. De Witt Hamer PC, Robles SG, Zwinderman AH, et al. Impact of intraoperative stimulation brain mapping on glioma surgery outcome: a meta-analysis. Journal of clinical oncology. 2012;30(20):2559-65.

  3. Raabe A, Beck J, Schucht P, et al. Continuous dynamic mapping of the corticospinal tract during surgery of motor eloquent brain tumors: evaluation of a new method. Journal of neurosurgery 2014;120(5):1015-24.

  4. Bello L, Riva M, Fava E, et al. Tailoring neurophysiological strategies with clinical context enhances resection and safety and expands indications in gliomas involving motor pathways. Neuro-oncology 2014;16(8):1110-28.

  5. Sala F, Lanteri P. Brain surgery in motor areas: the invaluable assistance of intraoperative neurophysiological monitoring. Journal of neurosurgical sciences 2003;47(2):79-88.

  6. Seidel K, Beck J, Stieglitz L, et al. The warning-sign hierarchy between quantitative subcortical motor mapping and continuous motor evoked potential monitoring during resection of supratentorial brain tumors. Journal of neurosurgery 2013;118(2):287-96.

  7. Smith JS, Chang EF, Lamborn KR, et al. Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas. Journal of clinical oncology. 2008;26(8):1338-45.

  8. Stummer W, Reulen HJ, Meinel T, et al. Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias. Neurosurgery 2008;62(3):564-76; discussion 64-76.

  9. Senft C, Bink A, Franz K, et al. Intraoperative MRI guidance and extent of resection in glioma surgery: a randomised, controlled trial. Lancet Oncol;12(11):997-1003.

  10. Sanai N, Snyder LA, Honea NJ, et al. Intraoperative confocal microscopy in the visualization of 5-aminolevulinic acid fluorescence in low-grade gliomas. J Neurosurg;115(4):740-8.

  11. McGirt MJ, Chaichana KL, Gathinji M, et al. Independent association of extent of resection with survival in patients with malignant brain astrocytoma. Journal of neurosurgery 2009;110(1):156-62.

  12. McGirt MJ, Chaichana KL, Attenello FJ, et al. Extent of surgical resection is independently associated with survival in patients with hemispheric infiltrating low-grade gliomas. Neurosurgery 2008;63(4):700-7; author reply 07-8.

  13. Lacroix M, Abi-Said D, Fourney DR, et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. Journal of neurosurgery 2001;95(2):190-8.

  14. De Witt Hamer PC, Robles SG, Zwinderman AH, et al. Impact of intraoperative stimulation brain mapping on glioma surgery outcome: a meta-analysis. J Clin Oncol;30(20):2559-65.

  15. Stummer W, Pichlmeier U, Meinel T, et al. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. The lancet oncology 2006;7(5):392-401.

Further reading

Books/book chapters

Journals